发明名称 |
MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY |
摘要 |
Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer. |
申请公布号 |
US2015218558(A1) |
申请公布日期 |
2015.08.06 |
申请号 |
US201514597676 |
申请日期 |
2015.01.15 |
申请人 |
Regulus Therapeutics Inc. |
发明人 |
Bhat Balkrishen;Marcusson Eric |
分类号 |
C12N15/113 |
主分类号 |
C12N15/113 |
代理机构 |
|
代理人 |
|
主权项 |
1. A compound comprising a modified oligonucleotide consisting of 8 to 22 linked nucleosides, wherein the nucleobase sequence of the modified oligonucleotide is complementary to miR-21 (SEQ ID NO: 1) and wherein the modified oligonucleotide comprises at least 8 contiguous nucleosides of the following nucleoside pattern III in the 5′ to 3′ orientation:
(R)X—NB—NQ—NQ—NB—(NQ—NQ—NQ—NB)3—NY—NZ wherein each R is a non-bicyclic nucleoside; X is from 1 to 4; each NB is a bicyclic nucleoside; each NQ is a non-bicyclic nucleoside; NY is a modified nucleoside or an unmodified nucleoside; and each NZ is a modified nucleoside. |
地址 |
San Diego CA US |